Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
how do you see ask at 0.25? which platform do you use?
the 'evil plan' is to liquidate..take the money and run and shut down operations.
that $3 million dollar lawsuit, the company has not paid any to the law firm as of april 4,2024. so way anyone who sent claims would have been paid. you a fool if you think humanigen would pay you a dime as the shareholder lawsuit was part of the scam to bankrupt the company. the claimants were fake too. there was no trial. or court hearing.
The 3 million dollar lawsuit has not been paid by humanigen so none of the .047/share settlement is paid as of april 4, 2024 which is 7 days ago. Why it took 1 years of litigation for this company to payout and insurance still has not paid. you drag it longer that 3 million minus legal fees has less than 1 million left in the pot. And reason the company wants to bail and liquidate company and not pay 3 milllion settlement. why pay. Insurance company has not wired the money to the law firm who supposedly was suppose to be receiving the money. but humanigen wants it and then wire it to the law firm who is the escrow and pay the .047/share. Insurance always wire the money to the company policy holder and then policy holder unless it gets permission to wire to law firm who claim the $3 million settlement.
Howdy, mates! Or should I say 'G,day, partners?'
"Hi Jay Booth, Aka Cowtown Jay,
There's been an update on Taran Pharma (Europe) Ltd in the last 24 hours:
Shareholders/Group Structure"
Management 'expects' the class 4,5 creditor which is the shareholders to get nothing in 'evil plan' to liquidate and shut down fraud operation. and needs the permission of the fake creditors and the Courts stamp of approval.
who still owns the 100 million shares? they didn't bother to get the tax capital loss? i think they didn't sell because if they sold their 100 million shares, they lose control of the bankruptcy process. The question who owns the 100 million shares and why nobody selling that 100 million shares. if you read the latest 'plan' it says equity owners get no nothing and management is asking the 'creditors' to agree to liquidation even though creditor nothing. why you need the creditor 'permission' for .
I plan to first sell a couple cheapies in the $60-$70 range... I'm posting this now to show proof that I care about the shorts and that I am doing my part to help them with their recovery.
It's trading on the Grey Sheets and why there is no volume. Listen I have a million shares for sale @ .40 cents that you can have if you want them, or you need to cover a serious short position. I will place it good for 60 days. As for the other 3 million shares I am just going to sit on them and wait this out.
If they disappear then so be it. This was a 1-800-GAMBLER moment for me anyhow! :)))
this bankruptcy case or chapter 11 court is mockery of justice and miscarriage of justice. you've got criminals who are charged with serious stock fraud, corporate embezzlment, filing fake claims etc. the people who run this stock scam also run 100 other stock scams all run by the same people in the backrupt. guys like durrants, chappel morhner the four employees are just frontman of this stock scam
it only had less than 3 million in liability and had 3 million in cash. without the 40 million bogus lawsuit its was not bankrupt and can easily raise addditonal capital but it wanted to go bankrupt by self sabotage it's business by signing contracts and breaking them deliberately and agreed to pay $3 million to a bogus investor lawsuit. for a company with no revenue and only 2 million in cash, a 3 million dollar payout would bankrupt the company. but it wanted to go bankrupt.
if this was legitimate company, it would not have gone bankrupt, lots of companies with no revenues can easily get investment or issue more shares to raise capital but this company had no intention of continue as viable business.
The guy who owns this company wants to go bankrupt hence no selling of any shares. he gets off legally clean if this scam court bankruptcy court case is done. If he sells the stock and someone owns 51% or controlling shares, the bankruptcy will not proceed. What HGENQ did was reject offer to the ip because it wants to go bankrupt. and the lawsuits or 'breach contract of 27 million and 7 million anther 3 million a total 40 million in bogus
claims' which prevented the company from getting any investment from potential investors. even if the 40 million was bogus lawsuit no investors would touch a company that is being sued by investors and suppliers. self sabotage my the owners to go bankrupt to make the shares worthless
The shares are WORTHLESS, why is not trading and ZERO volume? nobody selling any shares below .01/share
one guy owns 110 million shares and not selling. it worthless shares. bid is like .000001
idiot didn't sell to get tax writeoff? or get capital loss
The only new filing I see from the four companies I track (Humanigen, Baudax, Novavax, and Sanofi), is from an upset an investment firm holding Novavax. The comments provided by the investment firm are legitimate, and actually reflect why I feel that Novavax really needs to use lenz as their vaccine enhancement, if the company is going to survive.
https://www.sec.gov/Archives/edgar/data/1000694/000139834424007144/fp0087987-1_ex992.htm
Recent studies indicate that Novavax has an advantage in booster antibody durability. That's a plus, especially as mRNA booster antibodies are degrading, and becoming less effective. And it is becoming evident that Serious Adverse Events are presenting after a third mRNA booster.
I hope that Humanigen and Novavax can partner, and take the majority of the US covid market, currently captured by Moderna.gov (US govt), and PfDA (Pfizer/BioNtech and their German govt and European bank ownership).
Well, another newly created account for the purpose of helping us poor HGEN holders. How nice you are. Oh, you must know biowa and a few others like yourself.....very helpful people.
Even in bankruptcy, the court or public still don't know how the real owners of this company is....
as the delusional fool either he is getting paid to post about LENZ, there is no hope in this stock. one guy owns 90% of the shares and there is no way who that person is and it's probably taran..they need shut this stock scam over by dissolving and liquidating the scam operation. and move on to the next scam with stolen assets that they paid nothing for and hire new front man. Durant, chapeelle, rohnier all just hired hands and front man in this stock scam.
The stock since it was delisted to the 'expert market' short for banned market has not been buyerable for Americans or US regulated brokerages. Americans are not allowed to buy in the xpert market only able to sell.
Anyone buying stock in the expert market or OTC market knows 99% of the equities is worthless and will be worthless. only a few are ADR like tencents but they are not equities. and don't have to report to the SEC in quarterly reports. When buying ADR your name is not in the registered shareholders list. and shares are not registered as shares with ADR. but receipts
welcome to the jungle
welcome to my evil world.
in the mean streets and lawless jungle, if your rip someone off, and you know who ripp off, you don't sue them etc. you just go buy a gun and kill them and take back what was stolen
Once the courts lose their moral authority, the court and SEC no longer have legal authority to rule anything. meaning judgements and rulings have not enforceable or valid.
American fraud has been exported to many countries like China. the capitalist greed has corrupted the justice system, SEC, and even politicians. even crypto is a scam and SEC wants to regulate it yet more than 10% of the market is now ponzi scheme cryto financial instruments. a legal pyramid scheme or MLM with state approval. Once the courts lose their moral authority, the court and SEC no longer have legal authority to rule anything.
this is my observation and complaint of the American justice system and corrupt SEC and corrupt court system in helping crooks and theives steal and rip off the american public
eb is correct, oldstocks. I moved out of Fort Worth in 2008, but just across the county line, where it is still possible to buy land, and the taxes are significantly lower.
Dude… again with the fake screen name and profile for the what?? This is the 6th or 7th one?
Why? What do you gain from it?
lots of crimes
1. corporate embezzlement by management
2. misleading investors with false FDA approval
3. insurance scam, buys insurance and commmiting investor fraud
4. fake creditor claim submission deliberately signging contracts knowing it cannot commit ausin breach of contract lawsuit.
5. stock manipulatoin of the market makers.
this bankruptcy was a fraud. to clean the hands of the shorts who shorted the sharees in 2021 and transfer the assets which was the ip of lenz and close this stock scam and walk free and no jail with assistance from the gov't and cops(SEC) as for retail investors who go robbed, you won't get dime of that 3 million dollar settlement, that was an insurances scam too. 5 million had to paid out because the company paid $250,000/annual premium in insurance policy for lawsuits of managemennt corruption.
why spends millions to declare bankruptcy?
I hope the public is not pay for the Judge time wasting his time in this bogus court case.
even the trading is scam..AI front run humans and manipulate human traders. entire operation is like watching WWF wrestling match all this drama about bankruptcy .lawsuits. FDA approval, it's was a an act an fake. they want to go bankrupt with fake lawsuits and management deliberately sabotage the company with misconducts like embezzlment to cause a bankruptcy. this company only 5 million in debt in 2022 even if FDA didn't approve there was little chance of bankrupty as it had over 5 million in cash in 2022 and management could easily raise investment in 2021 or 2022 and raise more capital with share issuance when equity was still hot..but it's 2024 nobody wants to ivnest in money losing drug companies or vaccines anymore. SPAC ipo is dead. why reddit ddin't ipo in 2021 is beyond me, right now the market for equities dried up zero bid and even trading is dead, not even a dead cat bounce now.
as for this stock scam, it's gov't assisted robbery of public investors money. technically it's not illegal. but immoral but plan was to rip of investors from the beginning. from ipo like hundreds of these stocks and things like crypto. false hope and fomo etc when it was shell game. stock picking is scam. you are to choose 1 stock from 10 stock...all 10 stocks are scam. or shell game.no winners in all 10 stocks you were told to pick. investment fraud is what it is.
the latest scam is crypto ETF. when crypto classic pyramid scheme MLM scheme. collapses Cryto ETF and itself is MLM scam very similiar.
this stock is classic stock scam. wasting the courts time and SEC time etc. watching this case and this company is like watching WWF wrestling ...fake show. fake investment fraud. there was no investment opportunity. they took your money and not returning. by bankrupting the company with creating lawsuits and deliberately sabotaging the business with management misconduct. and yet nobody goes to jail everybody makes money except the ipo institutional investors who were bribed to buy these shares with other people's money and a few retail speculators. it was all a stock scam like many of the SPAC which ipo in 2021. Reddit waited too long why it didn't rush to ipo in 2021 when even a picture was bided on.
What plan? it's already bankrupt. no plan. but wait for death.
there is nothing to liquidate.
Why would you need creditor permission? if it wasn't for the bogus 27 million lawsuit, and bogus 3 million lawsuit humanigen would have gotten financing and no need to file chapter 11 to get the lawsuits off their back as that was what prevented and investment from new shareholders if it was not for the breach of contract lawsuits and self sabotaging by manageent to get the lawsuits this company could easily solicit investment banking or investments in 2022..it's 2024 and much harder to get any investment but that was part of the stock scam. The money was already made when it ipo and ripped off 160 million from ipo investors. when liquidity was a high. now these same companies if they were to ipo they won't get fraction of what they raised in 2021. many companies are not even ipo as no investors interest. in non=profit equities.
COMBINED CHAPTER 11 PLAN OF LIQUIDATION
AND DISCLOSURE STATEMENT FOR HUMANIGEN, INC
what is this? it's look like chapter 7. and dissolution of the company???
the company is worth only $100 cheaper than delaware incorporation.
will the company still trade as shell company?
I believe Jay lives near Ft Worth, which has the big stockyards.
Jay is cowtown for south jersey cowtown?
Welcome to the room, oldstocks, and thank you for your post.
I had stock in Planet Hollywood back in 1999/2000
On October 12, 1999, the company filed for Chapter 11 bankruptcy in an attempt to reorganize. They closed or sold poorly performing Planet Hollywood restaurants and Official All Star Cafes. It moved to focus to its original theme concept, stopping operation of Planet Movies by AMC and sold its Sound Republic units.
But shareholders got nothing
https://www.gainesville.com/story/news/2002/12/17/planet-hollywood-emerges-from-bankruptcy-again/31622270007/
Everything depends on how much the company paid for the assets in the sales.
Stockholders are the last ones to be paid after all debts are paid.
If all debts are paid can the remaining of what is left become a shell company and still trade or will all shares be canceled.
For shareholders at this point what do you have to lose by waiting to figure it out.
I hope the company was sold in a bidding war and i hope all shareholders get something
I can't say that you ARE reading it wrong, sosjtb.
"As soon as practicable after payment in full of, or reserve for, all other Allowed Claims, the Liquidating Trust shall
pay to each holder of an Allowed Subordinated Claim or an Allowed Existing Equity Interest its pro rata share of any
remaining amounts in the Liquidating Trust subject to the terms and conditions of this Combined Plan and Disclosure
Statement, the Liquidating Trust Agreement, and the Bankruptcy Code. No distribution to Class 4 (Subordinated
Claims) or Class 5 (Existing Equity Interests) is anticipated."
https://document.epiq11.com/document/getdocumentsbydocket/?docketId=1074462&projectCode=HUM&docketNumber=226&source=DM
p 33/65
But, you certainly COULD BE reading it wrong.
"As soon as practicable after payment in full of, or reserve for, all other Allowed Claims, the Liquidating Trust shall
pay to each holder of an Allowed Subordinated Claim or an Allowed Existing Equity Interest its pro rata share of any
remaining amounts in the Liquidating Trust subject to the terms and conditions of this Combined Plan and Disclosure
Statement, the Liquidating Trust Agreement, and the Bankruptcy Code. No distribution to Class 4 (Subordinated
Claims) or Class 5 (Existing Equity Interests) is anticipated...
there is no assurance that the Liquidating Trust will be successful in prosecuting any Cause of Action or generate sufficient
proceeds from the Causes of Action for Distribution. "
p 33/65 p 35/65
The case remains a CH11, and the recall of the loaned shares, especially if Novavax purchases the lenz/vaccine cocktail, or we combine/partner/merge through Taran into Sanofi, and get regulatory approval from Australia, perhaps with a PRV, we could easily see Ed Dowd announce a target price of $67 for our shares.
It’s over Jay, the plan of liquidation appears to show no recovery for shareholders and HGEN stock will be canceled in May…unless I’m reading that wrong?
"The new Humanigen may be stronger than I expected."
At one point, I actually questioned why the CH11 bankruptcy would be necessary. If Humanigen owns 110M of the 119M shares they have issued, and if our float of 229M shares is 192% of our OS, that could only mean that Humanigen has loaned the excess shares in our market. If so, Humanigen would be positioned to issue a recall of their loaned shares, and cause an even more massive short squeeze than they did as Kalobios.
I see no change in those circumstances.
I think Humanigen has held off recalling their loaned shares, until news, such as in regards to regulatory approval or authorization of lenzilumab, or news regarding a business combination/merger/partnership, was ready to be announced. This extended delay caused the financial constraints that forced the CH11 (as the US regulators tried to force us out of business, and protect their financial investment in Moderna, and promote their mRNA ideology, in my opinion).
I really think that Novavax may have used lenz as an enhancement in their prototype vaccine. I also think that Sanofi graduated, as Gracell did, from Humanigen's incubation of their their products, used with lenz for enhanced safety and efficacy. And I note how this CH11 is nearing completion as Sanofi prepares to spin-off their healthcare division, and the PREACH-M trial results are placed for regulatory approval in Australia, perhaps with a Priority Review Voucher worth ~$100M.
The only things that have changed are:
We may have partnership interests from Novavax, PREACH-M (and/or Sanofi), and Gracell (and perhaps AstraZeneca), exerting authorization approval of lenz from Regulators (probably overseas).
We have no secured debt obligations.
We have non-debtor Humanigen subsidiaries prepared for possible merger use in the UK, Australia, and the Republic of Ireland.
And we have shocking safety and efficacy failures, to include vaccine injuries and excess deaths, caused by the standard of care currently in use.
I'm very optimistic, and I believe that Humanigen has never been stronger than we are now.
Chapter 11 Plan of Liquidation filed with the court. Docket 226
https://document.epiq11.com/document/getdocumentsbydocket/?docketId=1074462&projectCode=HUM&docketNumber=226&source=DM
First of all, thank you for sharing that link, GURUBK. I'd certainly like to see our equity tied again to the IP rights, even if just by exclusive license. But I just don't think that this is going to happen solely by acquisition. Fine with me, if it does. The new Humanigen may be stronger than I expected. I just thought, and still think, that we'll see a merger, business combination, or partnerships factor into our new course, as well.
I'm interpreting an entirely different vibe, dlog. It seems that antibodies derived from vaccine-induced infection are weakening, and at the same time, the virulence of the next coronavirus to circulate, will be significantly worse than any strain or type that we have seen so far.
If so, then most of the covid that lenz will have to fight will be vaccine-induced, AND more deadly, unless the FDA prohibits mRNA vaccines, and authorizes lenz, before the next variant begins to circulate. I am very curious to see if lenz will be capable of restoring the the immune response in this scenario.
I hope you are right.
So, this means our stock is going to be brought back from the Dead the way I am interpreting this?
This could go multi-dollars once they file, and we go pink current. WOW!!!
Anybody holding shares here are sitting on a Goldmine!
Followers
|
327
|
Posters
|
|
Posts (Today)
|
7
|
Posts (Total)
|
43258
|
Created
|
01/31/13
|
Type
|
Free
|
Moderators DTGoody cowtown jay |
Humanigen, Inc. is a clinical-stage biopharmaceutical company developing its portfolio of next-generation cell and gene therapies for the treatment of cancers via its novel, GM-CSF neutralization and gene-knockout platforms. As a leader in GM-CSF pathway science, we believe that we have the ability to transform CAR-T therapy and a broad range of other T-cell engaging therapies, including both autologous and allogeneic cell transplantation. There is a direct correlation between the efficacy of CAR-T therapy and the incidence of life-threatening toxicities (referred to as the efficacy/toxicity linkage). We believe that our GM-CSF neutralization and gene-editing platform technologies have the potential to reduce the inflammatory cascade associated with serious and potentially life-threatening CAR-T therapy-related side effects while preserving and potentially improving the efficacy of the CAR-T therapy itself, thereby breaking the efficacy/toxicity linkage. Clinical correlative analysis and pre-clinical in vivo evidence points to GM-CSF as the key initiator of the inflammatory cascade resulting in CAR-T therapy’s side-effects. Pre-clinical in vivo data on the neutralization of GM-CSF using antibody or gene KO indicates that it is not required for CAR-T cell activity. Our strategy is to continue to pioneer the use of GM-CSF neutralization and GM-CSF gene knockout technologies to improve efficacy and prevent or significantly reduce the serious side-effects associated with CAR-T therapy.
We believe that our GM-CSF pathway science, assets and expertise create two technology platforms to usher in next-generation CAR-T therapies. Lenzilumab, our proprietary Humaneered® anti-GM-CSF immunotherapy, has the potential to be used in combination with any FDA-approved or development stage CAR-T therapy, as well as in combination with other cell therapies such as HSCT, to make these treatments safer and more effective. In addition, our GM-CSF knockout gene-editing platform has the potential to create next-generation CAR-T therapies that may inherently avoid any efficacy/toxicity linkage, thereby potentially preserving the benefits of the CAR-T therapy while altogether avoiding its serious and potentially life-threatening side-effects.
The company’s immediate focus is combining FDA-approved and development stage CAR-T therapies with lenzilumab, the company’s proprietary Humaneered® anti-human-GM-CSF immunotherapy, which is its lead product candidate. A clinical collaboration with Kite, a Gilead Company, was recently announced to evaluate the use of lenzilumab with Yescarta®, axicabtagene ciloleucel, in a multicenter clinical trial in adults with relapsed or refractory large B-cell lymphoma. The company is also focused on creating next-generation combinatory gene-edited CAR-T therapies using strategies to improve efficacy while employing GM-CSF gene knockout technologies to control toxicity. The company is also developing its own portfolio of proprietary first-in-class EphA3-CAR-T for various solid cancers and EMR1-CAR-T for various eosinophilic disorders. The company is also exploring the effectiveness of its GM-CSF neutralization technologies (either through the use of lenzilumab as a neutralizing antibody or through GM-CSF gene knockout) in combination with other CAR-T, T cell engaging, and immunotherapy treatments to break the efficacy/toxicity linkage including the prevention and/or treatment graft-versus-host disease (GvHD) in patients undergoing allogeneic HSCT. The company has established several partnerships with leading institutions to advance its innovative cell and gene therapy pipeline.
June 15, 2020
Phase 3 Study to Evaluate Efficacy and Safety of Lenzilumab in Hospitalized Patients With COVID-19 Pneumonia
https://clinicaltrials.gov/ct2/show/NCT04351152
Anti-GM-CSF antibodies expected to show better effect in Covid-19 than cytokine-specific targets
July 27, 2020
https://discoverysedge.mayo.edu/2021/06/22/cancer-to-covid-19/
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |